CLINICAL_TRIALS ClinicalTrials.gov record update

A Multicenter, Prospective Basket Clinical Trial of AI-Selected Traditional Chinese Medicine for Immune-Mediated Diseases and Investigation of Its Immunomodulatory Mechanisms

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT07901764
Title field or adapter rule: {'original_value': 'A Multicenter, Prospective Basket Clinical Trial of AI-Selected Traditional Chinese Medicine for Immune-Mediated Diseases and Investigation of Its Immunomodulatory Mechanisms', 'source_field': 'protocolSection.identificationModule.officialTitle'}
Ingested At: 2026-10-31T23:27:33.982745+00:00
Published At: 2026-10-28T00:00:00+00:00
Record Updated At: 2026-10-28
Source Retrieved At: 2026-10-31T22:18:41.628690+00:00
Timestamp Basis: ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Date limitation: ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

protocolSection.conditionsModule.conditions: ["IgA Nephropathy", "Kidney Transplant Recipients", "Lupus Nephritis", "Primary Membranous Nephropathy", "ANCA-associated Vasculitis", "Systemic Lupus Erythematosus", "Rheumatoid Arthritis (RA)", "Sjogren\u0027s Syndrome", "Hashimoto Thyroiditis"]
protocolSection.statusModule.lastUpdatePostDateStruct: {"date": "2026-10-28", "type": "ACTUAL"}
protocolSection.identificationModule.nctId: "NCT07901764"
protocolSection.identificationModule.officialTitle: "A Multicenter, Prospective Basket Clinical Trial of AI-Selected Traditional Chinese Medicine for Immune-Mediated Diseases and Investigation of Its Immunomodulatory Mechanisms"
protocolSection.statusModule.overallStatus: "NOT_YET_RECRUITING"
protocolSection.designModule.phases: ["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct: null

{'armGroupLabels': ['IgA Nephropathy + MYTP01', 'Kidney Transplant Recipients + MYTP01'], 'description': 'MYTP01 is a traditional Chinese herbal formula developed by clinical experts with the assistance of artificial intelligence (AI). It is administered orally as granules twice daily for 8 weeks in addition to standard medical treatment.', 'name': 'MYTP01', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['IgA Nephropathy + Placebo', 'Kidney Transplant Recipients + Placebo'], 'description': 'MYTP01 placebo is provided as oral granules designed to match MYTP01 in appearance and packaging to maintain blinding. It is administered twice daily for 8 weeks in addition to standard medical treatment, including immunosuppressive therapy as prescribed.', 'name': 'MYTP01 Placebo', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.